Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Frontiers in Neuroscience
|
October 17, 2025
Exploring the relationship between <i>GBA1</i> host genotype and gut microbiome in the <i>GBA1</i> <sup>L444P/WT</sup> mouse model: implications for Parkinson's disease pathogenesis
Elisa Menozzi, Mallia Geiger, Victoria Meslier, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease
Karen Louise Thomsen, Vikram Sharma, Helen Jones, et al.
NPJ Parkinson'S Disease
|
October 1, 2025
Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials
Elisa Menozzi, Sara Lucas Del Pozo, Jane Macnaughtan, et al.
JHEP Reports : Innovation in Hepatology
|
November 22, 2021
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
Annarein J C Kerbert, Saurabh Gupta, Eman Alabsawy, et al.
Nature Medicine
|
April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals
Elisa Menozzi, Yani Ren, Mallia Geiger, et al.
Gut
|
April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
Jinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Frontiers in Neuroscience
|
October 17, 2025
Exploring the relationship between <i>GBA1</i> host genotype and gut microbiome in the <i>GBA1</i> <sup>L444P/WT</sup> mouse model: implications for Parkinson's disease pathogenesis
Elisa Menozzi, Mallia Geiger, Victoria Meslier, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease
Karen Louise Thomsen, Vikram Sharma, Helen Jones, et al.
NPJ Parkinson'S Disease
|
October 1, 2025
Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials
Elisa Menozzi, Sara Lucas Del Pozo, Jane Macnaughtan, et al.
JHEP Reports : Innovation in Hepatology
|
November 22, 2021
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
Annarein J C Kerbert, Saurabh Gupta, Eman Alabsawy, et al.
Nature Medicine
|
April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals
Elisa Menozzi, Yani Ren, Mallia Geiger, et al.
Gut
|
April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
Jinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Page
of 4